ASEP MED HLDGS Stock Price, News & Analysis
Company Description
ASEP MED HLDGS (OTC Link: SEPSF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.3M.
SEPSF stock has declined 97.3% over the past year. Shares last traded at $0.0109.
This page provides a comprehensive overview of SEPSF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ASEP MED HLDGS (SEPSF) stock last traded at $0.0109. Over the past 12 months, the stock has lost 97.3%. At a market capitalization of $4.3M, SEPSF is classified as a micro-cap stock with approximately 11.1M shares outstanding.
Latest News
ASEP MED HLDGS has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include AI. View all SEPSF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
SEPSF Company Profile & Sector Positioning
ASEP MED HLDGS (SEPSF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SEPSF often look at related companies in the same sector, including Tron Group (TGRP), Nymox Pharm (NYMXF), Orgenesis Inc (ORGS), Kane Biotech Inc (KNBIF), and Vaxxinity, Inc. (VAXX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SEPSF's relative position within its industry.